Logo Precision Medicine in Chronic Inflammation
DE EN

Klinisches Symposium PMI 2020

Begleitprogramm für praktizierende Ärztinnen und Ärzte (auf Deutsch und Englisch) im Rahmen des Internationalen Symposiums
Zertifiziert durch die Ärztekammer Hamburg (3 Fortbildungspunkte pro Session)

18. Februar 2020, 18:30-20:30

Please check back regularly for updates.

Program

Program of the Symposium as pdf-file

Sunday, February 16, 2020

Monday, February 17, 2020

08:00 - 09:00
Foyer, 2nd floor
Arrival and registration
09:00 - 09:10
Conference hall New York, 2nd floor

Welcome Address

Stefan Schreiber - Kiel University, Spokesperson of the Clusters of Excellence “Inflammation at Interfaces” and “Precision Medicine in Chronic Inflammation”
09:10 - 10:10
Conference hall New York, 2nd floor

Session I

Final colloquium Cluster of Excellence “Inflammation at Interfaces” - Highlights and achievements
    Chairs:
  • Stefan Schreiber - Kiel University
  • Enno Hartmann - University of Lübeck
    Talks:
  • Stefan Schreiber - Kiel University
    Microbiota as a target in IBD
  • Stefan Rose-John - Kiel University
    Blockade of IL-6 Trans-Signaling in Inflammation and Cancer
  • Ralf Ludwig - University of Lübeck
    Skin Autoimmunity Research within I@I: Structural Achievements and Reseach Highlights
10:10 - 10:40
Foyer, 2nd floor
Coffee break / snacks
10:40 - 12:30
Conference hall New York, 2nd floor

Session II

High resolution imaging and innovative technologies – From basic science to clinical use
    Chairs:
  • Jörg Köhl - University of Lübeck
  • Jan-Bernd Hövener - Kiel University
    Talks:
  • Robert Huber - University of Lübeck
    Trends and perspectives of advanced optics and optical coherence tomography (OCT) in medicine
  • Friedrich Feuerhake - Hannover Medical School (MHH), Hannover, DE
    Qualitative and quantitative histological evaluation of inflammation
  • Björn Eskofier - Friedrich-Alexander University (FAU), Erlangen, DE
    Wearable Computing and Machine Learning for Digital Health and Precision Medicine
  • Alison Simmons - University of Oxford, Oxford, GB
    Mapping Mucosal Cell Remodeling in Colitis
12:30 - 13:30
tbd
Lunch break
13:30 - 15:00

PARALLEL FOCUSED WORKSHOPS

  • 1. Animal models

    tbd
    Chairs: Jörg Köhl, Oliver Pabst
    Impulse talk: Oliver Pabst
    Going wild - Animal models in the microbiota age
  • 2. Clinical sequencing

    tbd
    Chairs: Jeanette Erdmann, Andre Franke
    Impulse talk: Dermot McGovern req.
  • 3. Nutrition in personalized medicine

    tbd
    Chairs: Matthias Laudes, Karin Schwarz
    Impulse talk: Matthias Laudes
    Targeted Nutrition Medicine for Metabolic Inflammation
  • 4. Imaging modalities

    tbd
    Chair: Robert Huber
    Impulse talk: Robert Huber
    Contribution of advanced Imaging to Precision Medicine
  • 5. Organoids and stem cells

    tbd
    Chair: Christine Klein
    Impulse talk: tbd
15:00 - 15:30
Foyer, 2nd floor
Coffee break / snacks
15:30 - 17:10
Conference hall New York, 2nd floor

Session III

Microbiome as an intervention target – Is it coming?
    Chairs:
  • Philip Rosenstiel - Kiel University
  • Hinrich Schulenburg - Kiel University
    Talks:
  • John Baines - Kiel University and Max Planck Institute Plön
    Evolutionary perspectives on gut microbiome intervention
  • Jeroen Raes - Rega Institute, Leuven, BE
    Quantitative microbiome profiling in health and disease
  • Oliver Pabst - RTWH Aachen University, Aachen, DE
    Shaping of antibody responses to the microbiota
  • Petra Bacher - Kiel University
    Human T helper cell responses against intestinal microbiota
17:10 - 18:00
Free time
Break (at free disposal)
18:00 - 22:00
tbd

Poster Session & Get-together

with buffet

Tuesday, February 18, 2020

08:30 - 10:10
Conference hall New York, 2nd floor

Session IV

Genetics and disease behavior – genotype, phenotype, what type?
    Chairs:
  • Stephan Weidinger - Kiel University
  • Andre Franke - Kiel University
    Talks:
  • David Ellinghaus - Kiel University
    Protein-coding variants contribute to the risk of atopic dermatitis and skin-specific gene expression
  • Dermot McGovern - Cedars-Sinai Medical Center, Los Angeles, US
    Genotype x Phenotype in Crohn’s disease: the path to personalized medicine.
  • Carl Anderson - Sanger Institute, Cambridge, GB
    Using genome sequencing to understand the causes and consequences of IBD
  • Jeanette Erdmann - University of Lübeck
    Is there any news on the genetics of cardiovascular diseases?
10:10 - 10:40
Foyer, 2nd floor
Coffee break / snacks
1040 - 12:20
Conference hall New York, 2nd floor

Session V

Treatment to target – Biomarker, endophenotyping and stratified medicine
    Chairs:
  • Diamant Thaçi - University of Lübeck
  • Ulf Müller-Ladner - University of Gießen
    Talks:
  • Gabriela Riemekasten - University of Lübeck
    Autoantibodies as biomarkers and pathogenic drivers for precision medicine in inflammation
  • Philip Helliwell - University of Leeds, Leeds, GB
    Tight control or treat to target in rheumatology
  • James G. Krueger - The Rockefeller University, New York, US
  • Philip Rosenstiel - Kiel University
    Multi-Omics in IBD - are we on track for a more precise medicine ?
12:20 - 13:20
tbd
Lunch break
13:20 - 14:50

PARALLEL FOCUSED WORKSHOPS

  • 6. Antibiotic resistance and evolutionary medicine

    Conference room Tokio, 2nd floor
    Chairs: Klaus F. Rabe, Hinrich Schulenburg
    Impulse talk: Hinrich Schulenburg
    Charles Darwin meets the antibiotic crisis: can we use evolutionary principles to prevent resistance evolution?
  • 7. Immunophenotyping

    Conference room Mexico, 2nd floor
    Chairs: Alexander Scheffold, David Klatzmann
    Impulse talk: David Klatzmann
    T Cell receptor sequencing for predicting efficacy and side effects of immunotherapies
  • 8. Patient reported outcomes

    Conference room Shanghai, 2nd floor
    Chairs: Stefan Schreiber, Philip Helliwell req.
    Impulse talk: Philip Helliwell req.
    Impulse talk: Johan Burisch
  • 9. How to publish in big journals – equal opportunity for everyone?

    Room tbd
    Chairs: Petra Bacher, Jennifer Sargent
    Impulse talk: Philip Rosenstiel
    Prepare for years
    Impulse talk: Petra Bacher
    Be creative
    Impulse talk: David Ellinghaus
    Collaboration counts
    Impulse talk: Stefan Schreiber
    No more animal experiments?
    Impulse talk: tbd
    Technology counts
    Impulse talk: Jennifer Sargent
    Writing up in a smart way
14:50 - 15:20
Foyer, 2nd floor
Coffee break / snacks
15:20 - 17:10
Conference hall New York, 2nd floor

Session VI

Predictors of response and treatment optimization in PMI
    Chairs:
  • Bimba F. Hoyer - Kiel University
  • Christian Sadik - University of Lübeck
    Talks:
  • Diamant Thaçi - University of Lübeck
  • Ursula Grohmann - University of Perugia, Perugia, IT
    Immune checkpoint molecules and personalized medicine in autoimmune diabetes and neuroinflammation
  • Emma Guttman - Mount Sinai Hospital, New York, US
  • David Klatzmann - Sorbonne University, Paris, FR
    Optimizing and individualizing IL-2 therapy of autoimmune and inflammatory diseases
17:10 - 17:35
tbd (Conference hall New York, 2nd floor)

Closing remarks and Poster Awards

Stefan Schreiber - Kiel University
17:35 - 18:30
Foyer, 2nd floor
Snack break / refreshments
18:30 - 20:30
tbd

Sponsored Clinical Session I

IL-4 and IL-13 in focus: New Therapies for atopic Dermatitis and Asthma
(Language: German apart from State-of-the-Art-Talks)
Sponsored by
Logo sanofi
    Chairs:
  • Diamant Thaçi - University of Lübeck
  • Klaus F. Rabe - LungenClinic Grosshansdorf
    Welcome:
  • Diamant Thaçi
    Tandem talk: Lunge vs. Haut
  • Diamant Thaçi and Klaus F. Rabe
    Komorbidität und Therapie - was ist gleich, was ist anders?
    State-of-the-Art-Talks:
    (Language: English)
  • Emma Guttman - Mount Sinai Hospital, New York, US
    The road towards a personalized medicine approach in atopic dermatitis
  • Luca Richeldi - A. Gemelli University Hospital – IRCCS, Rome, IT
    Precision Medicine in interstitial lung diseases
    Summary and discussion:
  • Diamant Thaçi and Klaus F. Rabe
18:30 - 20:30
tbd

Sponsored Clinical Session II

TNF and IL-23 in focus: New Therapies for CED, Rheumatoid Arthritis and Psoriasis
(Language: German apart from State-of-the-Art-Talks)
Sponsored by
Logo abbvie
    Chairs:
  • Stefan Schreiber - Kiel University
  • Bimba F. Hoyer - Kiel University
    Welcome:
  • Stefan Schreiber
    Tandem talk: Gastro vs. Rheuma
  • Stefan Schreiber and Bimba F. Hoyer
    Therapie und Komplikations­manage­ment - Gemeinsamkeiten und Unterschiede
    State-of-the-Art-Talks:
    (Language: English)
  • James G. Krueger - The Rockefeller University, New York, US
    Psoriasis from the perspective of precision medicine in chronic inflammation
  • Johan Burisch - Hvidovre Hospital, DK
    eHealth and individualized monitoring in inflammatory bowel disease
    Summary and discussion:
  • Stefan Schreiber and Bimba F. Hoyer
20:30
Foyer, 2nd floor
Snacks and collegial exchange